Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2018 Jan 20

PMID 29351207

Citations 55

Authors

Rahima Muhammad Kashim

Paul Newton

Omorogieva Ojo

Affiliations

Soon will be listed here.

Abstract

Diabetic Retinopathy is a microvascular complication of diabetes, that can go undetected and unnoticed until irreversible damage and even blindness has occurred. Effective screening for diabetic retinopathy has been proven to reduce the risk of sight loss. The National Health Service (NHS) which provides healthcare for all UK citizens, implemented systematic retinal screening for diabetic retinopathy in England in 2003, with the aim of identifying and treating all patients with sight threatening retinopathy. Crucial to this is patients partaking in the programme. Therefore, increasing screening uptake has been a major focus of the programme. This review explores the views of people living with diabetes who do not attend retinal screening, their characteristics, concerns, experiences of retinal screening and their understanding of the risks of diabetic retinopathy. All studies that satisfied the study inclusion criteria on 'patients' non-attendance at retinal screening', between 2003 to 2017 were included after extensive database search. A total of 16 studies were included in the review. Findings showed that socio-economic deprivation was a major risk factor for non-attendance, about 11.5-13.4% of the screened population had sight threatening retinopathy (STDR), repeated nonattendance was linked to sight threatening diabetic retinopathy, and that certain factors, could be barriers or incentives for screening uptake. Some of those factors are modifiable whilst others are not.

Citing Articles

Exploring patient and health care provider perspectives on barriers to diabetic retinopathy screening in public health facilities in North India.

Chauhan A, Duggal M, Kankaria A, Gupta V, Dhiman S, Singh M Sci Rep. 2025; 15(1):8251.

PMID: 40065058 PMC: 11894220. DOI: 10.1038/s41598-025-92795-y.

Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study.

Silwal P, Pirouzi M, Murphy R, Harwood M, Grey C, Squirrell D BMJ Open. 2025; 15(1):e087650.

PMID: 39890153 PMC: 11784328. DOI: 10.1136/bmjopen-2024-087650.

Barriers for adherence to diabetic retinopathy screening among Saudi adult population, 2023.

Alamri A, Alamri M, Alolayani R, Assiri S, Alshehri R, Alshabab S J Family Community Med. 2024; 31(4):305-312.

PMID: 39619460 PMC: 11604187. DOI: 10.4103/jfcm.jfcm_104_24.

Awareness, Knowledge, Attitudes, and Practices Regarding Diabetic Retinopathy Among Residents of Jazan City, Saudi Arabia.

Alagsam A, Alhazmi E, Mobarki O, Mojiri M, Najmi A, Zurayyir E Cureus. 2024; 16(10):e71219.

PMID: 39525213 PMC: 11550144. DOI: 10.7759/cureus.71219.

PSAT1 is upregulated by METTL3 to attenuate high glucose-induced retinal pigment epithelial cell apoptosis and oxidative stress.

Du X, Wang Y, Gao F Diagn Pathol. 2024; 19(1):138.

PMID: 39407268 PMC: 11476401. DOI: 10.1186/s13000-024-01556-4.

References

Maric-Bilkan C . Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clin Sci (Lond). 2017; 131(9):833-846. DOI: 10.1042/CS20160998. View

Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J . Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012; 57(4):347-70. DOI: 10.1016/j.survophthal.2012.01.004. View

Zoega G, Gunnarsdottir T, Bjornsdottir S, Hreietharsson A, Viggosson G, Stefansson E . Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand. 2006; 83(6):687-90. DOI: 10.1111/j.1600-0420.2005.00541.x. View

Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R . Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr. 2012; 6(4):199-202. DOI: 10.1016/j.dsx.2012.08.009. View

Lake A, Browne J, Rees G, Speight J . What factors influence uptake of retinal screening among young adults with type 2 diabetes? A qualitative study informed by the theoretical domains framework. J Diabetes Complications. 2017; 31(6):997-1006. DOI: 10.1016/j.jdiacomp.2017.02.020. View

Zheng Y, He M, Congdon N . The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012; 60(5):428-31. PMC: 3491270. DOI: 10.4103/0301-4738.100542. View

Leese G, Boyle P, Feng Z, Emslie-Smith A, Ellis J . Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008; 31(11):2131-5. PMC: 2571062. DOI: 10.2337/dc08-1098. View

Hartnett M, Key I, Loyacano N, Horswell R, DeSalvo K . Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005; 123(3):387-91. DOI: 10.1001/archopht.123.3.387. View

Strutton R, Du Chemin A, Stratton I, Forster A . System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open. 2016; 6(5):e010952. PMC: 4874146. DOI: 10.1136/bmjopen-2015-010952. View

10.

van Eijk K, Blom J, Gussekloo J, Polak B, Groeneveld Y . Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes Res Clin Pract. 2011; 96(1):10-6. DOI: 10.1016/j.diabres.2011.11.003. View

11.

Millett C, Dodhia H . Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen. 2006; 13(3):152-5. DOI: 10.1258/096914106778440608. View

12.

Gulliford M, Dodhia H, Chamley M, McCormick K, Mohamed M, Naithani S . Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med. 2010; 27(3):282-8. DOI: 10.1111/j.1464-5491.2010.02946.x. View

13.

Peto T, Tadros C . Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom. Curr Diab Rep. 2012; 12(4):338-45. DOI: 10.1007/s11892-012-0285-4. View

14.

Scanlon P, Carter S, Foy C, Husband R, Abbas J, Bachmann M . Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen. 2008; 15(3):118-21. DOI: 10.1258/jms.2008.008013. View

15.

Scanlon P, Aldington S, Stratton I . Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol. 2013; 20(4):293-300. PMC: 3841946. DOI: 10.4103/0974-9233.120007. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

17.

Hipwell A, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, OHare P . Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening. BMJ Open. 2014; 4(12):e005498. PMC: 4267079. DOI: 10.1136/bmjopen-2014-005498. View

18.

Tarr J, Kaul K, Chopra M, Kohner E, Chibber R . Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2014; 2013:343560. PMC: 3914226. DOI: 10.1155/2013/343560. View

19.

Dervan E, Lillis D, Flynn L, Staines A, OShea D . Factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci. 2008; 177(4):303-8. DOI: 10.1007/s11845-008-0192-5. View

20.

Forster A, Forbes A, Dodhia H, Connor C, du Chemin A, Sivaprasad S . Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study. Diabetologia. 2013; 56(10):2187-93. DOI: 10.1007/s00125-013-2975-0. View